NL7623.
Study name |
Public title: DEcrease STress through RESilience training for Students Scientific title: DEcrease STress through RESilience training for Students |
Methods |
Study design: hybrid design: longitudinal observational cohort with nested RCT Study grouping: parallel group (IG vs CG); sequential multiple assignment Unit of randomisation: individuals Power (power sample size calculation, level of power achieved): not specified in trial registration Imputation of missing data: not specified |
Participants |
Country: The Netherlands Setting: not specified Age: not specified Sample size (randomised): 706 targeted Sex: not specified Comorbidity (mean (SD) of respective measures in indicated, if available) at baseline: not specified Population description: students at the Erasmus University Medical Centre Rotterdam, aged 16 years and older, who provide informed consent and have a score of 14 or higher on the PSS‐10 Method of recruitment: not specified Inclusion criteria: eligible for longitudinal cohort study: 1) all medical students, research master students, PhD students, nanobiology and clinical technology students at the Erasmus University Medical Centre (Erasmus MC) Rotterdam; 2) aged 16 years or older; 3) who give informed consent; within observational cohort, students fulfilling the following criteria are included in the nested RCT: 1) participation in the cohort study; 2) score of 14 or higher on the PSS‐10 Exclusion criteria: A student who meets any of the following criteria will be excluded from participation in the RCT, but can participate in the cohort study: 1) not insured for health care (for care provided in The Netherlands); 2) diagnosis of, or previously treated for, psychosis or mania; 3) response to at least 1 question on the Four‐Dimensional Symptom Questionnaire (4DSQ) items 33 or 46 is “often” or “very often or constantly" Attrition (withdrawals and exclusions): not specified Reasons for missing data: not specified |
Interventions |
Intervention: multiple behavioural interventions (n randomised not specified)
Control: active control (n randomised not specified)
|
Outcomes |
Outcomes collected and reported: Primary outcome
Secondary outcomes
Outcomes reported not specified Time points measured and reported: 1) pre‐intervention; 2) post‐intervention (before and after each 8‐week intervention period); 3) 1‐year follow‐up; 4) 2‐year follow‐up;time points reported not specified Adverse events: not specified |
Starting date | Study start/end date: February 2019 ‐ September 2023 |
Contact information |
Principal investigator: Prof. Myriam Hunink Address: Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands Email: m.hunink@erasmusmc.nl Telephone: +31107043489 |
Notes |
Contact with authors: no correspondence required Funding source: Erasmus MC, Studie Voorschot Middelen Declaration of interest: not specified in trial registration Ethical approval needed/obtained for study: not specified in trial registration Comments by study authors: website, destress.info Miscellaneous outcomes by the review authors:trialregister.nl/trial/7623 (trial register number assigned 22 March 2019); according to trial registration, the recruitment status is 'recruiting' |